Authors:
Nickerson, ML
Warren, MB
Zbar, B
Schmidt, LS
Citation: Ml. Nickerson et al., Random mutagenesis-PCR to introduce alterations into defined DNA sequencesfor validation of SNP and mutation detection methods, HUM MUTAT, 17(3), 2001, pp. 210-219
Authors:
Miller, M
Ginalski, K
Lesyng, B
Nakaigawa, N
Schmidt, L
Zbar, B
Citation: M. Miller et al., Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies, PROTEINS, 44(1), 2001, pp. 32-43
Authors:
Danilkovitch-Miagkova, A
Miagkov, A
Skeel, A
Nakaigawa, N
Zbar, B
Leonard, EJ
Citation: A. Danilkovitch-miagkova et al., Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway, MOL CELL B, 21(17), 2001, pp. 5857-5868
Authors:
Dreijerink, K
Braga, E
Kuzmin, I
Geil, L
Duh, FM
Angeloni, D
Zbar, B
Lerman, MI
Stanbridge, EJ
Minna, JD
Protopopov, A
Li, JF
Kashuba, V
Klein, G
Zabarovsky, ER
Citation: K. Dreijerink et al., The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3is involved in kidney tumorigenesis, P NAS US, 98(13), 2001, pp. 7504-7509
Authors:
Schmidt, LS
Warren, MB
Nickerson, ML
Weirich, G
Matrosova, V
Toro, JR
Turner, ML
Duray, P
Merino, M
Hewitt, S
Pavlovich, CP
Glenn, G
Greenberg, CR
Linehan, WM
Zbar, B
Citation: Ls. Schmidt et al., Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2, AM J HU GEN, 69(4), 2001, pp. 876-882
Authors:
Nakaigawa, N
Weirich, G
Schmidt, L
Zbar, B
Citation: N. Nakaigawa et al., Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src, ONCOGENE, 19(26), 2000, pp. 2996-3002
Authors:
Libutti, SK
Choyke, PL
Alexander, HR
Glenn, G
Bartlett, DL
Zbar, B
Lubensky, I
McKee, SA
Maher, ER
Linehan, WM
Walther, MM
Citation: Sk. Libutti et al., Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease, SURGERY, 128(6), 2000, pp. 1022-1027
Authors:
Ornstein, DK
Lubensky, IA
Venzon, D
Zbar, B
Linehan, WM
Walther, MM
Citation: Dk. Ornstein et al., Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer, J UROL, 163(2), 2000, pp. 431-433
Authors:
Mohr, VH
Vortmeyer, AO
Zhuang, ZP
Libutti, SK
Walther, MM
Choyke, PL
Zbar, B
Linehan, WM
Lubensky, IA
Citation: Vh. Mohr et al., Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients, AM J PATH, 157(5), 2000, pp. 1615-1621
Authors:
Sgambati, MT
Stolle, C
Choyke, PL
Walther, MM
Zbar, B
Linehan, WM
Glenn, GM
Citation: Mt. Sgambati et al., Mosaicism in von Hippel-Lindau disease: Lessons from kindreds with germline mutations identified in offspring with mosaic parents, AM J HU GEN, 66(1), 2000, pp. 84-91
Authors:
Schmidt, L
Junker, K
Nakaigawa, N
Kinjerski, T
Weirich, G
Miller, M
Lubensky, I
Neumann, HPH
Brauch, H
Decker, J
Vocke, C
Brown, JA
Jenkins, R
Richard, S
Bergerheim, U
Gerrard, B
Dean, M
Linehan, WM
Zbar, B
Citation: L. Schmidt et al., Novel mutations of the MET proto-oncogene in papillary renal carcinomas, ONCOGENE, 18(14), 1999, pp. 2343-2350
Authors:
Gorospe, M
Egan, JM
Zbar, B
Lerman, M
Geil, L
Kuzmin, I
Holbrook, NJ
Citation: M. Gorospe et al., Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells, MOL CELL B, 19(2), 1999, pp. 1289-1300
Authors:
Walther, MM
Reiter, R
Keiser, HR
Choyke, PL
Venzon, D
Hurley, K
Gnarra, JR
Reynolds, JC
Glenn, GM
Zbar, B
Linehan, WM
Citation: Mm. Walther et al., Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: Comparison with sporadic pheochromocytoma gives insight intonatural history of pheochromocytoma, J UROL, 162(3), 1999, pp. 659-664
Authors:
Ohh, M
Takagi, Y
Aso, T
Stebbins, CE
Pavletich, NP
Zbar, B
Conaway, RC
Conaway, JW
Kaelin, WG
Citation: M. Ohh et al., Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein, J CLIN INV, 104(11), 1999, pp. 1583-1591
Authors:
Pack, SD
Zbar, B
Pak, E
Ault, DO
Humphrey, JS
Pham, T
Hurley, K
Weil, RJ
Park, WS
Kuzmin, I
Stolle, C
Glenn, G
Liotta, LA
Lerman, MI
Klausner, RD
Linehan, WM
Zhuang, ZP
Citation: Sd. Pack et al., Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization, CANCER RES, 59(21), 1999, pp. 5560-5564
Authors:
Park, WS
Dong, SM
Kim, SY
Na, EY
Shin, MS
Pi, JH
Kim, BJ
Bae, JH
Hong, YK
Lee, KS
Lee, SH
Yoo, NJ
Jang, JJ
Pack, S
Zhuang, ZP
Schmidt, L
Zbar, B
Lee, JY
Citation: Ws. Park et al., Somatic mutations in the kinase domain of the MET/hepatocyte growth factorreceptor gene in childhood hepatocellular carcinomas, CANCER RES, 59(2), 1999, pp. 307-310
Authors:
Cohen, HT
Zhou, M
Welsh, AM
Zarghamee, S
Scholz, H
Mukhopadhyay, D
Kishida, T
Zbar, B
Knebelmann, B
Sukhatme, VP
Citation: Ht. Cohen et al., An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association, BIOC BIOP R, 266(1), 1999, pp. 43-50
Authors:
Lubensky, IA
Schmidt, L
Zhuang, ZP
Weirich, G
Pack, S
Zambrano, N
Walther, MM
Choyke, P
Linehan, WM
Zbar, B
Citation: Ia. Lubensky et al., Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype, AM J PATH, 155(2), 1999, pp. 517-526